HDL Cholesterol Not As Useful for Predicting MI in Minority Patients

June 23, 2020


While often referred to as "Good cholesterol" new research suggests HDL measurements do little for predicting risk of heart attack in Black patients

Tai Chi Improves Mental Well-Being of Patients with Cardiovascular Disease

June 09, 2020


A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.

Blood Pressure Treatment Adherence Reduces Mortality, Regardless of Frailty

June 08, 2020


A new analysis examines impact of treatment adherence in more than 1.2 million patients.

FDA Approves Ticagrelor DAPT for Patients Without CVD, Stroke History

June 01, 2020


The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.

Muthiah Vaduganathan, MD: Real-World Impact of Comprehensive HFrEF Therapy

May 29, 2020


Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.

AHA Seeks to Address Health Disparities in American Indians, Alaska Natives

May 28, 2020


The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.

Diets Rich in Fruits and Vegetables Lower Cardiac Strain, Damage

May 21, 2020


A new analysis of the DASH trial found a fruit-and-vegetable diet was associated with lower levels of hs-cTnl and NT-proBNP.

Nearly One-in-Ten Vascular Events, Infections, and Cancers are Misdiagnosed

May 16, 2020


A new analysis of 28 studies including more than 90k patients suggests 1-in-10 of these conditions is misdiagnosed, results in delays in treatment and potential harm.

CD34+ Cell Therapy Effective for Reducing Angina in NOCAD in Clinical Trial

May 15, 2020


Data presented at SCAI 2020 examining a novel cell therapy suggests it could help reduce angina in patients with non-obstructive coronary artery disease.

Analysis Indicates SYNERGY Stents Safe, Efficacious in High-Risk Patients

May 15, 2020


An analysis of the TWILIGHT trial presented at SCAI examines SYNERGY BP-EES in a high-risk patient population.